What does Dr. Bleus - Dr. Cambier do?

Dr. Bleus - Dr. Cambier is a specialist medical practice in Hasselt. Private Limited, started on 25 February 2005, 1 establishment.

What is the address of Dr. Bleus - Dr. Cambier?

The registered office of Dr. Bleus - Dr. Cambier is located at Henegauwlaan 59, 3500 Hasselt.

Is Dr. Bleus - Dr. Cambier still active?

Yes. According to the CBE (3 October 2026) Dr. Bleus - Dr. Cambier is active, legal situation “Normale toestand”, started on 25 February 2005.

Is Dr. Bleus - Dr. Cambier registered on Peppol?

Yes, Dr. Bleus - Dr. Cambier is registered on the Peppol network with ID 0208:0872141549.

What is the enterprise number of Dr. Bleus - Dr. Cambier?

The enterprise number of Dr. Bleus - Dr. Cambier is BE0872141549.

When was Dr. Bleus - Dr. Cambier founded?

Dr. Bleus - Dr. Cambier was founded on 25 February 2005.

Who are the directors of Dr. Bleus - Dr. Cambier?

According to the 2024 annual accounts, the directors of Dr. Bleus - Dr. Cambier are: Edith Bleus, Jean Philippe Cambier.

Is Dr. Bleus - Dr. Cambier a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 February 2005; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did Dr. Bleus - Dr. Cambier make in 2024?

Dr. Bleus - Dr. Cambier posted a profit after taxes of € 321,421 in financial year 2024.

What is the revenue of Dr. Bleus - Dr. Cambier?

As a small company, Dr. Bleus - Dr. Cambier is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 476,547.

Dr. Bleus - Dr. Cambier (Private Limited) - Hasselt

Dossier Dr. Bleus - Dr. Cambier, printed on 3 October 2026 from databakkes.be/en/0872141549/dr-bleus-dr-cambier. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. Bleus - Dr. Cambier from Hasselt, company number BE0872141549, closed financial year 2024 with a result of € 321,421 after tax. For that financial year Dr. Bleus - Dr. Cambier recorded a gross margin of € 476,547 and equity of € 1 million. Compared with financial year 2023, the result moved from € 140,381 to € 321,421. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.

What it is worth Growing

€ 1 million

▲ 46% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 321,421

▲ 129% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 101,047

▲ 102% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 1 million.

People and assets in 2024

Vehicles and equipment

€ 27,966

▼ 38% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 20,000

▼ 31% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 6,752

▼ 75% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 83,546

▲ 14% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 324,408 Gross margin 2021: € 324,408 First fiscal year in the series	€ 373,827 Gross margin 2022: € 373,827 ▲ 15% vs 2021 (€ 324,408) Favourable step	€ 356,642 Gross margin 2023: € 356,642 ▼ 5% vs 2022 (€ 373,827) Unfavourable step	€ 476,547 Gross margin 2024: € 476,547 ▲ 34% vs 2023 (€ 356,642) Favourable step	▲ 34%
Profit after taxes	€ 126,405 Profit after taxes 2021: € 126,405 First fiscal year in the series	€ 147,577 Profit after taxes 2022: € 147,577 ▲ 17% vs 2021 (€ 126,405) Favourable step	€ 140,381 Profit after taxes 2023: € 140,381 ▼ 5% vs 2022 (€ 147,577) Unfavourable step	€ 321,421 Profit after taxes 2024: € 321,421 ▲ 129% vs 2023 (€ 140,381) Favourable step	▲ 129%
Equity	€ 655,407 Equity 2021: € 655,407 First fiscal year in the series	€ 709,227 Equity 2022: € 709,227 ▲ 8% vs 2021 (€ 655,407) Favourable step	€ 705,891 Equity 2023: € 705,891 Unchanged (€ 709,227) Unfavourable step	€ 1,027,312 Equity 2024: € 1,027,312 ▲ 46% vs 2023 (€ 705,891) Favourable step	▲ 46%
Total debts	€ 247,903 Total debts 2021: € 247,903 First fiscal year in the series	€ 244,272 Total debts 2022: € 244,272 ▼ 1% vs 2021 (€ 247,903) Favourable step	€ 265,953 Total debts 2023: € 265,953 ▲ 9% vs 2022 (€ 244,272) Unfavourable step	€ 112,149 Total debts 2024: € 112,149 ▼ 58% vs 2023 (€ 265,953) Favourable step	▼ 58%
Cash	€ 164,066 Cash 2021: € 164,066 First fiscal year in the series	€ 83,451 Cash 2022: € 83,451 ▼ 49% vs 2021 (€ 164,066) Unfavourable step	€ 50,131 Cash 2023: € 50,131 ▼ 40% vs 2022 (€ 83,451) Unfavourable step	€ 101,047 Cash 2024: € 101,047 ▲ 102% vs 2023 (€ 50,131) Favourable step	▲ 102%
Land & buildings	-	€ 31,823 Land & buildings 2022: € 31,823 First fiscal year in the series	€ 30,937 Land & buildings 2023: € 30,937 ▼ 3% vs 2022 (€ 31,823) Unchanged	€ 30,051 Land & buildings 2024: € 30,051 ▼ 3% vs 2023 (€ 30,937) Unchanged	▼ 3%
Retained profit	€ 643,007 Retained profit 2021: € 643,007 First fiscal year in the series	€ 696,827 Retained profit 2022: € 696,827 ▲ 8% vs 2021 (€ 643,007) Favourable step	€ 693,491 Retained profit 2023: € 693,491 Unchanged (€ 696,827) Unfavourable step	€ 1,014,912 Retained profit 2024: € 1,014,912 ▲ 46% vs 2023 (€ 693,491) Favourable step	▲ 46%
Dividend	€ 80,966 Dividend 2021: € 80,966 First fiscal year in the series	€ 93,756 Dividend 2022: € 93,756 ▲ 16% vs 2021 (€ 80,966) Unchanged	€ 143,716 Dividend 2023: € 143,716 ▲ 53% vs 2022 (€ 93,756) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 143,716) Unchanged	▼ 100%
Bank debt	€ 101,259 Bank debt 2021: € 101,259 First fiscal year in the series	€ 74,373 Bank debt 2022: € 74,373 ▼ 27% vs 2021 (€ 101,259) Favourable step	€ 28,834 Bank debt 2023: € 28,834 ▼ 61% vs 2022 (€ 74,373) Favourable step	€ 20,000 Bank debt 2024: € 20,000 ▼ 31% vs 2023 (€ 28,834) Favourable step	▼ 31%
Balance sheet total	€ 1,002,360 Balance sheet total 2021: € 1,002,360 First fiscal year in the series	€ 1,051,524 Balance sheet total 2022: € 1,051,524 ▲ 5% vs 2021 (€ 1,002,360) Unchanged	€ 1,078,635 Balance sheet total 2023: € 1,078,635 ▲ 3% vs 2022 (€ 1,051,524) Unchanged	€ 1,139,461 Balance sheet total 2024: € 1,139,461 ▲ 6% vs 2023 (€ 1,078,635) Unchanged	▲ 6%

Key figures of Dr. Bleus - Dr. Cambier, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. Bleus - Dr. Cambier?

What happened at Dr. Bleus - Dr. Cambier in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2025 New annual accounts for financial year 2024: profit of € 321,421 (▲ 129% vs 2023). filed late Source: NBB ↗
2024 Edith Bleus became a director. NBB
2024 Jean Philippe Cambier became a director. NBB
Feb 25, 2005 New establishment in Hasselt. KBO
Feb 25, 2005 Start of the company according to the CBE. KBO

In short

From € 126,405 profit in 2021 to € 321,421 profit in 2024.

Paid € 313,834 in corporate taxes since 2021.

Best year ever: 2024, with € 321,421 profit.

Paid out € 318,439 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Bleus - Dr. Cambier? We notify you, reason included.

Follow Dr. Bleus - Dr. Cambier

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Edith Bleus Jean Philippe Cambier

Dr. Bleus - Dr. Cambier

Behind Dr. Bleus - Dr. Cambier are Edith Bleus and Jean Philippe Cambier.

See the full network in the app

Directors

According to the 2024 annual accounts

Edith Bleus

Statutair bestuurder

since 2024

Jean Philippe Cambier

Statutair bestuurder

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Henegauwlaan 59

3500 Hasselt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0872.141.549
VAT number: BE 0872.141.549
Registered office: Henegauwlaan 59, 3500 Hasselt
Names & denominations: Dr. Bleus - Dr. Cambier
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 February 2005
Peppol: Active · Active since 6 May 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗